Alginate hydrogels: A potential tissue engineering intervention for intervertebral disc degeneration

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Regenerative Medicine

Background:

• Intervertebral disc (IVD) degeneration is a primary cause of low back pain and disability globally.
• Current treatments for IVD degeneration are limited, often involving invasive surgery or pain management.
• Biomaterials, particularly alginate hydrogels, are gaining attention for IVD degeneration treatment.

Purpose of the Study:

• To provide a comprehensive overview of alginate hydrogels for treating IVD degeneration.
• To discuss the properties, applications, and mechanisms of alginate hydrogels in IVD regeneration.
• To highlight current research outcomes, challenges, and future directions in this field.

Main Methods:

• Review of current literature on alginate hydrogels for IVD degeneration.
• Discussion of alginate hydrogel properties (biocompatibility, mechanical properties).
• Analysis of alginate hydrogels' potential in delivering therapeutic agents for IVD repair.

Main Results:

• Alginate hydrogels are biocompatible and can mimic the native IVD extracellular matrix.
• They offer localized and sustained release of therapeutic agents like growth factors or cells.
• Research indicates potential for alginate hydrogels in IVD regeneration, though challenges remain.

Conclusions:

• Alginate hydrogels represent a promising biomaterial for IVD degeneration treatment and regeneration.
• Further research is needed to address challenges related to mechanical properties, biocompatibility, and surgical compatibility.
• Optimizing alginate hydrogels could lead to improved therapeutic strategies for low back pain and disability.